Our study detected CA9 in 25 of 28 seromas of patients with in situ (stage IA) BIA-ALCL compared with 4 of 11 in situ samples and 7 tumor stage in the study by Oishi et al. [10]. The gene discussed is CA9; the disease is neoplasm.